Share Price and Basic Stock Data
Last Updated: December 11, 2025, 1:42 pm
| PEG Ratio | -5.95 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Bharat Rasayan Ltd operates in the agro-chemicals sector, focusing on manufacturing pesticides and related products. As of the latest financial data, the company’s market capitalization stood at ₹4,115 Cr, with a share price of ₹9,903. Over the past few years, Bharat Rasayan has witnessed fluctuations in its revenue streams. For instance, total sales reported for FY 2025 amounted to ₹1,171 Cr, a decline from ₹1,234 Cr in FY 2023, but a slight recovery is noted with TTM sales at ₹1,268 Cr. Quarterly sales also reveal variability, with the most recent quarter showing ₹310 Cr in revenue, following a dip to ₹239 Cr in June 2023. This erratic sales pattern raises questions about demand stability and market conditions, especially in a sector heavily influenced by monsoon patterns and agricultural cycles. The company’s ability to adapt to these fluctuations will be crucial for maintaining its revenue trajectory.
Profitability and Efficiency Metrics
Profitability for Bharat Rasayan presents a mixed picture. The net profit for FY 2025 was recorded at ₹141 Cr, representing an increase from ₹125 Cr in FY 2023. However, the operating profit margin (OPM) has seen a decline, standing at 15% for FY 2025 compared to 15% in FY 2023, and significantly down from 19% in FY 2022. This trend could indicate rising cost pressures or inefficiencies that need to be addressed. The company’s return on equity (ROE) is reported at 12.4%, while return on capital employed (ROCE) is slightly higher at 15.5%, reflecting a reasonable efficiency in utilizing equity and capital. Moreover, the interest coverage ratio at an impressive 42.56x suggests that Bharat Rasayan is comfortably managing its debt obligations, which is a positive sign in terms of financial health.
Balance Sheet Strength and Financial Ratios
The balance sheet of Bharat Rasayan appears robust, characterized by low borrowings of just ₹90 Cr against reserves of ₹1,193 Cr. This translates to a debt-to-equity ratio of merely 0.07, indicating a conservative approach to leverage. The company’s current ratio stands at a healthy 4.19, suggesting that it has more than enough short-term assets to cover its liabilities, which is crucial for operational stability. However, the cash conversion cycle (CCC) of 200 days could be considered on the higher side, pointing to potential inefficiencies in inventory management or receivables collection. Overall, while the financial ratios paint a picture of strength, the elevated CCC could be an area for improvement, affecting liquidity and operational agility.
Shareholding Pattern and Investor Confidence
Investor confidence in Bharat Rasayan is reflected in its stable shareholding pattern. Promoters hold a commanding 74.99% stake, which exhibits a strong commitment to the company’s long-term vision. Foreign institutional investors (FIIs) have gradually increased their stake to 0.47%, while domestic institutional investors (DIIs) now stand at 2.75%. The public shareholding is around 21.79%, with a total of 15,388 shareholders. This distribution indicates a solid base of support, albeit with a low presence of institutional investors, which could suggest limited institutional interest in the stock. The high promoter holding coupled with a gradual uptick in FIIs may bolster investor confidence, but it also raises questions about the liquidity of the stock in the market.
Outlook, Risks, and Final Insight
Looking ahead, Bharat Rasayan’s prospects hinge on its ability to navigate the challenges inherent in the agro-chemical sector, including fluctuations in raw material costs and changing regulatory landscapes. While the company boasts a solid balance sheet and a committed promoter base, its performance metrics indicate areas needing improvement, particularly in profitability and operational efficiency. Risks include potential supply chain disruptions and the impact of monsoon seasons on agricultural demand for pesticides. Investors might view Bharat Rasayan as a stable yet cautious play in the agro-chemical industry, weighing the benefits of its strong financial position against the backdrop of market volatility and sector-specific challenges. The stock’s premium valuation, reflected in a P/E ratio of 28.6, may also be a consideration for those assessing its long-term potential versus immediate financial performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Bharat Rasayan Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 6,157 Cr. | 1,427 | 2,195/1,398 | 15.3 | 487 | 0.42 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 785 Cr. | 232 | 391/165 | 16.2 | 131 | 0.00 % | 12.0 % | 9.28 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 66.9 Cr. | 128 | 149/56.6 | 12.0 | 40.0 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 2,953 Cr. | 228 | 345/224 | 111 | 54.9 | 0.07 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 857 Cr. | 362 | 670/244 | 66.9 | 342 | 0.82 % | 12.9 % | 9.95 % | 10.0 |
| Industry Average | 11,005.00 Cr | 1,445.25 | 31.78 | 472.46 | 0.44% | 15.21% | 19.87% | 7.25 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 327 | 292 | 309 | 306 | 239 | 263 | 233 | 310 | 282 | 328 | 256 | 307 | 377 |
| Expenses | 276 | 256 | 260 | 249 | 234 | 250 | 207 | 240 | 244 | 281 | 215 | 270 | 308 |
| Operating Profit | 51 | 36 | 49 | 56 | 6 | 13 | 26 | 69 | 38 | 47 | 42 | 37 | 69 |
| OPM % | 16% | 12% | 16% | 18% | 2% | 5% | 11% | 22% | 14% | 14% | 16% | 12% | 18% |
| Other Income | 8 | 3 | 6 | -3 | 9 | 4 | 4 | 22 | 22 | 7 | 18 | 6 | -8 |
| Interest | 2 | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 6 | 7 | 7 | 6 | 6 | 6 | 7 | 6 | 6 | 6 | 7 | 7 | 6 |
| Profit before tax | 51 | 31 | 46 | 46 | 8 | 10 | 22 | 84 | 53 | 46 | 52 | 35 | 54 |
| Tax % | 26% | 26% | 27% | 34% | 8% | 39% | 29% | 20% | 19% | 30% | 21% | 27% | 26% |
| Net Profit | 38 | 23 | 34 | 30 | 7 | 6 | 15 | 67 | 43 | 32 | 41 | 25 | 40 |
| EPS in Rs | 90.63 | 55.18 | 81.27 | 72.80 | 17.06 | 14.44 | 36.84 | 161.50 | 103.77 | 77.35 | 97.54 | 60.48 | 95.44 |
Last Updated: August 20, 2025, 12:50 pm
Below is a detailed analysis of the quarterly data for Bharat Rasayan Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 377.00 Cr.. The value appears strong and on an upward trend. It has increased from 307.00 Cr. (Mar 2025) to 377.00 Cr., marking an increase of 70.00 Cr..
- For Expenses, as of Jun 2025, the value is 308.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 270.00 Cr. (Mar 2025) to 308.00 Cr., marking an increase of 38.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 69.00 Cr.. The value appears strong and on an upward trend. It has increased from 37.00 Cr. (Mar 2025) to 69.00 Cr., marking an increase of 32.00 Cr..
- For OPM %, as of Jun 2025, the value is 18.00%. The value appears strong and on an upward trend. It has increased from 12.00% (Mar 2025) to 18.00%, marking an increase of 6.00%.
- For Other Income, as of Jun 2025, the value is -8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2025) to -8.00 Cr., marking a decrease of 14.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 6.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 7.00 Cr. (Mar 2025) to 6.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 54.00 Cr.. The value appears strong and on an upward trend. It has increased from 35.00 Cr. (Mar 2025) to 54.00 Cr., marking an increase of 19.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Mar 2025) to 26.00%, marking a decrease of 1.00%.
- For Net Profit, as of Jun 2025, the value is 40.00 Cr.. The value appears strong and on an upward trend. It has increased from 25.00 Cr. (Mar 2025) to 40.00 Cr., marking an increase of 15.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 95.44. The value appears strong and on an upward trend. It has increased from 60.48 (Mar 2025) to 95.44, marking an increase of 34.96.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:36 am
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 989 | 1,213 | 1,091 | 1,301 | 1,234 | 1,044 | 1,171 | 1,268 |
| Expenses | 802 | 983 | 852 | 1,050 | 1,043 | 926 | 996 | 1,074 |
| Operating Profit | 188 | 230 | 240 | 250 | 191 | 118 | 175 | 195 |
| OPM % | 19% | 19% | 22% | 19% | 15% | 11% | 15% | 15% |
| Other Income | 1 | 14 | 6 | 16 | 15 | 35 | 42 | 23 |
| Interest | 16 | 16 | 4 | 7 | 6 | 3 | 5 | 5 |
| Depreciation | 17 | 22 | 26 | 25 | 26 | 26 | 27 | 27 |
| Profit before tax | 155 | 205 | 215 | 234 | 174 | 123 | 185 | 186 |
| Tax % | 28% | 23% | 24% | 25% | 28% | 23% | 24% | |
| Net Profit | 112 | 158 | 164 | 176 | 125 | 96 | 141 | 137 |
| EPS in Rs | 262.48 | 371.03 | 385.69 | 423.51 | 299.88 | 229.85 | 339.13 | 330.81 |
| Dividend Payout % | 1% | 0% | 0% | 0% | 0% | 1% | 0% |
YoY Net Profit Growth
| Year | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 41.07% | 3.80% | 7.32% | -28.98% | -23.20% | 46.88% |
| Change in YoY Net Profit Growth (%) | 0.00% | -37.27% | 3.52% | -36.29% | 5.78% | 70.08% |
Bharat Rasayan Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2019-2020 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -1% |
| 3 Years: | -3% |
| TTM: | 17% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -4% |
| 3 Years: | -9% |
| TTM: | 12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 2% |
| 3 Years: | -7% |
| 1 Year: | -20% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 16% |
| 3 Years: | 12% |
| Last Year: | 12% |
Last Updated: September 5, 2025, 12:55 am
Balance Sheet
Last Updated: December 4, 2025, 1:03 am
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves | 405 | 560 | 723 | 766 | 889 | 984 | 1,126 | 1,193 |
| Borrowings | 247 | 94 | 58 | 174 | 28 | 80 | 85 | 90 |
| Other Liabilities | 100 | 94 | 122 | 142 | 152 | 129 | 193 | 168 |
| Total Liabilities | 756 | 752 | 908 | 1,086 | 1,074 | 1,197 | 1,408 | 1,456 |
| Fixed Assets | 150 | 203 | 191 | 228 | 225 | 230 | 230 | 223 |
| CWIP | 35 | 18 | 18 | 11 | 11 | 6 | 15 | 25 |
| Investments | 0 | 9 | 150 | 43 | 67 | 143 | 298 | 298 |
| Other Assets | 570 | 522 | 549 | 803 | 771 | 818 | 865 | 910 |
| Total Assets | 756 | 752 | 908 | 1,086 | 1,074 | 1,197 | 1,408 | 1,456 |
Below is a detailed analysis of the balance sheet data for Bharat Rasayan Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,193.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,126.00 Cr. (Mar 2025) to 1,193.00 Cr., marking an increase of 67.00 Cr..
- For Borrowings, as of Sep 2025, the value is 90.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 85.00 Cr. (Mar 2025) to 90.00 Cr., marking an increase of 5.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 168.00 Cr.. The value appears to be improving (decreasing). It has decreased from 193.00 Cr. (Mar 2025) to 168.00 Cr., marking a decrease of 25.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,456.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,408.00 Cr. (Mar 2025) to 1,456.00 Cr., marking an increase of 48.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 223.00 Cr.. The value appears to be declining and may need further review. It has decreased from 230.00 Cr. (Mar 2025) to 223.00 Cr., marking a decrease of 7.00 Cr..
- For CWIP, as of Sep 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2025) to 25.00 Cr., marking an increase of 10.00 Cr..
- For Investments, as of Sep 2025, the value is 298.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 298.00 Cr..
- For Other Assets, as of Sep 2025, the value is 910.00 Cr.. The value appears strong and on an upward trend. It has increased from 865.00 Cr. (Mar 2025) to 910.00 Cr., marking an increase of 45.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,456.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,408.00 Cr. (Mar 2025) to 1,456.00 Cr., marking an increase of 48.00 Cr..
Notably, the Reserves (1,193.00 Cr.) exceed the Borrowings (90.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | -59.00 | 136.00 | 182.00 | 76.00 | 163.00 | 38.00 | 90.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 103 | 75 | 99 | 130 | 96 | 138 | 131 |
| Inventory Days | 112 | 70 | 90 | 120 | 141 | 135 | 136 |
| Days Payable | 24 | 17 | 33 | 30 | 33 | 37 | 67 |
| Cash Conversion Cycle | 191 | 128 | 156 | 221 | 204 | 236 | 200 |
| Working Capital Days | 96 | 94 | 114 | 136 | 165 | 199 | 170 |
| ROCE % | 34% | 31% | 28% | 20% | 12% | 16% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| PGIM India Midcap Fund | 63,964 | 0.6 | 69.41 | N/A | N/A | N/A |
| PGIM India Small Cap Fund | 25,978 | 1.73 | 28.19 | 26,931 | 2025-12-08 02:13:57 | -3.54% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 339.14 | 229.86 | 299.89 | 423.52 | 385.70 |
| Diluted EPS (Rs.) | 339.14 | 229.86 | 299.89 | 423.52 | 385.70 |
| Cash EPS (Rs.) | 366.02 | 258.47 | 377.50 | 486.31 | 447.73 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 2719.48 | 2377.47 | 2149.86 | 1853.14 | 1711.78 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 2719.48 | 2377.47 | 2149.86 | 1853.14 | 1711.78 |
| Revenue From Operations / Share (Rs.) | 2822.97 | 2514.02 | 2970.60 | 3131.39 | 2570.20 |
| PBDIT / Share (Rs.) | 483.49 | 332.50 | 521.37 | 651.03 | 580.53 |
| PBIT / Share (Rs.) | 418.54 | 270.43 | 458.73 | 591.01 | 519.90 |
| PBT / Share (Rs.) | 407.18 | 263.32 | 433.75 | 565.14 | 508.26 |
| Net Profit / Share (Rs.) | 301.07 | 196.40 | 314.86 | 426.29 | 387.10 |
| NP After MI And SOA / Share (Rs.) | 339.14 | 229.86 | 299.89 | 423.53 | 385.70 |
| PBDIT Margin (%) | 17.12 | 13.22 | 17.55 | 20.79 | 22.58 |
| PBIT Margin (%) | 14.82 | 10.75 | 15.44 | 18.87 | 20.22 |
| PBT Margin (%) | 14.42 | 10.47 | 14.60 | 18.04 | 19.77 |
| Net Profit Margin (%) | 10.66 | 7.81 | 10.59 | 13.61 | 15.06 |
| NP After MI And SOA Margin (%) | 12.01 | 9.14 | 10.09 | 13.52 | 15.00 |
| Return on Networth / Equity (%) | 12.47 | 9.66 | 13.94 | 22.85 | 22.53 |
| Return on Capital Employeed (%) | 15.15 | 11.23 | 21.10 | 31.43 | 29.94 |
| Return On Assets (%) | 10.00 | 7.97 | 11.60 | 16.14 | 18.04 |
| Total Debt / Equity (X) | 0.07 | 0.08 | 0.03 | 0.22 | 0.08 |
| Asset Turnover Ratio (%) | 0.90 | 0.91 | 1.14 | 1.30 | 1.32 |
| Current Ratio (X) | 4.19 | 4.60 | 4.64 | 2.59 | 3.82 |
| Quick Ratio (X) | 3.08 | 3.25 | 2.74 | 1.70 | 2.83 |
| Inventory Turnover Ratio (X) | 2.96 | 2.30 | 2.85 | 4.16 | 4.04 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.65 | 0.50 | 0.00 | 0.38 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.51 | 0.41 | 0.00 | 0.33 |
| Earning Retention Ratio (%) | 0.00 | 99.35 | 99.50 | 0.00 | 99.62 |
| Cash Earning Retention Ratio (%) | 0.00 | 99.49 | 99.59 | 0.00 | 99.67 |
| Interest Coverage Ratio (X) | 42.56 | 46.73 | 37.31 | 39.68 | 67.02 |
| Interest Coverage Ratio (Post Tax) (X) | 27.50 | 28.60 | 24.32 | 27.56 | 46.03 |
| Enterprise Value (Cr.) | 4407.24 | 3562.69 | 3772.42 | 5228.04 | 4021.85 |
| EV / Net Operating Revenue (X) | 3.76 | 3.41 | 3.06 | 4.02 | 3.68 |
| EV / EBITDA (X) | 21.94 | 25.79 | 17.41 | 19.33 | 16.31 |
| MarketCap / Net Operating Revenue (X) | 3.73 | 3.38 | 3.06 | 3.89 | 3.66 |
| Retention Ratios (%) | 0.00 | 99.34 | 99.49 | 0.00 | 99.61 |
| Price / BV (X) | 3.87 | 3.57 | 4.23 | 6.57 | 5.49 |
| Price / Net Operating Revenue (X) | 3.73 | 3.38 | 3.06 | 3.89 | 3.66 |
| EarningsYield | 0.03 | 0.02 | 0.03 | 0.03 | 0.04 |
After reviewing the key financial ratios for Bharat Rasayan Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 339.14. This value is within the healthy range. It has increased from 229.86 (Mar 24) to 339.14, marking an increase of 109.28.
- For Diluted EPS (Rs.), as of Mar 25, the value is 339.14. This value is within the healthy range. It has increased from 229.86 (Mar 24) to 339.14, marking an increase of 109.28.
- For Cash EPS (Rs.), as of Mar 25, the value is 366.02. This value is within the healthy range. It has increased from 258.47 (Mar 24) to 366.02, marking an increase of 107.55.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2,719.48. It has increased from 2,377.47 (Mar 24) to 2,719.48, marking an increase of 342.01.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2,719.48. It has increased from 2,377.47 (Mar 24) to 2,719.48, marking an increase of 342.01.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2,822.97. It has increased from 2,514.02 (Mar 24) to 2,822.97, marking an increase of 308.95.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 483.49. This value is within the healthy range. It has increased from 332.50 (Mar 24) to 483.49, marking an increase of 150.99.
- For PBIT / Share (Rs.), as of Mar 25, the value is 418.54. This value is within the healthy range. It has increased from 270.43 (Mar 24) to 418.54, marking an increase of 148.11.
- For PBT / Share (Rs.), as of Mar 25, the value is 407.18. This value is within the healthy range. It has increased from 263.32 (Mar 24) to 407.18, marking an increase of 143.86.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 301.07. This value is within the healthy range. It has increased from 196.40 (Mar 24) to 301.07, marking an increase of 104.67.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 339.14. This value is within the healthy range. It has increased from 229.86 (Mar 24) to 339.14, marking an increase of 109.28.
- For PBDIT Margin (%), as of Mar 25, the value is 17.12. This value is within the healthy range. It has increased from 13.22 (Mar 24) to 17.12, marking an increase of 3.90.
- For PBIT Margin (%), as of Mar 25, the value is 14.82. This value is within the healthy range. It has increased from 10.75 (Mar 24) to 14.82, marking an increase of 4.07.
- For PBT Margin (%), as of Mar 25, the value is 14.42. This value is within the healthy range. It has increased from 10.47 (Mar 24) to 14.42, marking an increase of 3.95.
- For Net Profit Margin (%), as of Mar 25, the value is 10.66. This value exceeds the healthy maximum of 10. It has increased from 7.81 (Mar 24) to 10.66, marking an increase of 2.85.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.01. This value is within the healthy range. It has increased from 9.14 (Mar 24) to 12.01, marking an increase of 2.87.
- For Return on Networth / Equity (%), as of Mar 25, the value is 12.47. This value is below the healthy minimum of 15. It has increased from 9.66 (Mar 24) to 12.47, marking an increase of 2.81.
- For Return on Capital Employeed (%), as of Mar 25, the value is 15.15. This value is within the healthy range. It has increased from 11.23 (Mar 24) to 15.15, marking an increase of 3.92.
- For Return On Assets (%), as of Mar 25, the value is 10.00. This value is within the healthy range. It has increased from 7.97 (Mar 24) to 10.00, marking an increase of 2.03.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.07. This value is within the healthy range. It has decreased from 0.08 (Mar 24) to 0.07, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.90. It has decreased from 0.91 (Mar 24) to 0.90, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 4.19. This value exceeds the healthy maximum of 3. It has decreased from 4.60 (Mar 24) to 4.19, marking a decrease of 0.41.
- For Quick Ratio (X), as of Mar 25, the value is 3.08. This value exceeds the healthy maximum of 2. It has decreased from 3.25 (Mar 24) to 3.08, marking a decrease of 0.17.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.96. This value is below the healthy minimum of 4. It has increased from 2.30 (Mar 24) to 2.96, marking an increase of 0.66.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 0.65 (Mar 24) to 0.00, marking a decrease of 0.65.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 0.51 (Mar 24) to 0.00, marking a decrease of 0.51.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 99.35 (Mar 24) to 0.00, marking a decrease of 99.35.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 99.49 (Mar 24) to 0.00, marking a decrease of 99.49.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 42.56. This value is within the healthy range. It has decreased from 46.73 (Mar 24) to 42.56, marking a decrease of 4.17.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 27.50. This value is within the healthy range. It has decreased from 28.60 (Mar 24) to 27.50, marking a decrease of 1.10.
- For Enterprise Value (Cr.), as of Mar 25, the value is 4,407.24. It has increased from 3,562.69 (Mar 24) to 4,407.24, marking an increase of 844.55.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.76. This value exceeds the healthy maximum of 3. It has increased from 3.41 (Mar 24) to 3.76, marking an increase of 0.35.
- For EV / EBITDA (X), as of Mar 25, the value is 21.94. This value exceeds the healthy maximum of 15. It has decreased from 25.79 (Mar 24) to 21.94, marking a decrease of 3.85.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.73. This value exceeds the healthy maximum of 3. It has increased from 3.38 (Mar 24) to 3.73, marking an increase of 0.35.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 99.34 (Mar 24) to 0.00, marking a decrease of 99.34.
- For Price / BV (X), as of Mar 25, the value is 3.87. This value exceeds the healthy maximum of 3. It has increased from 3.57 (Mar 24) to 3.87, marking an increase of 0.30.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.73. This value exceeds the healthy maximum of 3. It has increased from 3.38 (Mar 24) to 3.73, marking an increase of 0.35.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bharat Rasayan Ltd:
- Net Profit Margin: 10.66%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.15% (Industry Average ROCE: 15.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 12.47% (Industry Average ROE: 19.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 27.5
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.08
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 28.7 (Industry average Stock P/E: 31.78)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.07
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.66%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agro Chemicals/Pesticides | 1501, Vikram Tower, Rajendra Place, New Delhi Delhi 110008 | investors.brl@bharatgroup.co.in http://www.bharatgroup.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sat Narain Gupta | Chairman & Managing Director |
| Mr. Mahabir Prasad Gupta | Whole Time Director |
| Mr. Rajender Prasad Gupta | WholeTime Director & CEO |
| Mr. Ajay Gupta | Executive Director |
| Mr. Kamleshwar Prasad Uniyal | Executive Director |
| Mrs. Sujata Agarwal | Ind. Non-Executive Director |
| Mr. Suresh Kumar Garg | Ind. Non-Executive Director |
| Mr. Ankit Aggarwal | Ind. Non-Executive Director |
| Ms. Mukta Gupta | Ind. Non-Executive Director |
| Mr. Rajesh Gupta | Ind. Non-Executive Director |
| Mr. Naman Jain | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Bharat Rasayan Ltd?
Bharat Rasayan Ltd's intrinsic value (as of 11 December 2025) is 8203.14 which is 17.22% lower the current market price of 9,910.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 4,118 Cr. market cap, FY2025-2026 high/low of 12,121/8,798, reserves of ₹1,193 Cr, and liabilities of 1,456 Cr.
What is the Market Cap of Bharat Rasayan Ltd?
The Market Cap of Bharat Rasayan Ltd is 4,118 Cr..
What is the current Stock Price of Bharat Rasayan Ltd as on 11 December 2025?
The current stock price of Bharat Rasayan Ltd as on 11 December 2025 is 9,910.
What is the High / Low of Bharat Rasayan Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bharat Rasayan Ltd stocks is 12,121/8,798.
What is the Stock P/E of Bharat Rasayan Ltd?
The Stock P/E of Bharat Rasayan Ltd is 28.7.
What is the Book Value of Bharat Rasayan Ltd?
The Book Value of Bharat Rasayan Ltd is 2,881.
What is the Dividend Yield of Bharat Rasayan Ltd?
The Dividend Yield of Bharat Rasayan Ltd is 0.01 %.
What is the ROCE of Bharat Rasayan Ltd?
The ROCE of Bharat Rasayan Ltd is 15.5 %.
What is the ROE of Bharat Rasayan Ltd?
The ROE of Bharat Rasayan Ltd is 12.4 %.
What is the Face Value of Bharat Rasayan Ltd?
The Face Value of Bharat Rasayan Ltd is 10.0.